New drug, Cialis, to challenge Viagra in Korea: survey

Published: 2004-01-12 06:59:00

Updated: 2004-01-12 06:59:00

In the domestic market for male impotence drugs, Lilly's Cialis encompassed 44.4 percent of new prescriptions in December of last year, challenging a dominant rival, Viagra, a recent survey showed.

Lilly Korea said that to investigate the prescription rate of male impotence drugs from last Oct...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK